Residency · Residency · Interventional Radiology
Percutaneous Cholecystostomy
Overview
Percutaneous cholecystostomy is the image-guided placement of a drainage catheter into the gallbladder for decompression of acute cholecystitis. Primarily indicated in critically ill patients who are poor surgical candidates for cholecystectomy. Performed under ultrasound and/or fluoroscopic guidance with local anesthesia and sedation. Serves as a temporizing measure or, in some cases, definitive therapy.
Indications
Acute Calculous Cholecystitis
Critically ill patients (ICU, septic, multiorgan failure) who cannot tolerate surgery. Patients on anticoagulation with high bleeding risk for cholecystectomy. Severe comorbidities (ASA IV-V) precluding general anesthesia. Bridge to interval cholecystectomy once patient stabilized.
Acute Acalculous Cholecystitis
Occurs in critically ill patients (post-surgical, burns, trauma, TPN-dependent). Gallbladder distension, wall thickening, and pericholecystic fluid without stones. Percutaneous drainage is often the primary treatment. Higher mortality than calculous cholecystitis (reflects underlying patient acuity).
Other Indications
Gallbladder empyema. Gallbladder perforation with contained abscess. Access route for percutaneous gallstone extraction or cholecystolithotomy (rare). Staging before biliary interventions when transhepatic access is not feasible.
Technique
Pre-Procedural Assessment
Ultrasound confirmation of gallbladder pathology (distension, wall thickening >3 mm, pericholecystic fluid, sonographic Murphy sign). CT may demonstrate gallbladder inflammation, perforation, or abscess. Coagulation assessment: INR ≤1.5, platelets ≥50,000 (SIR moderate bleeding risk). Antibiotics initiated prior to procedure (broad-spectrum coverage for gram-negatives and anaerobes).
Access Route
| Feature | Transhepatic (Preferred) | Transperitoneal |
|---|---|---|
| Route | Through hepatic parenchyma (segment V) | Direct through peritoneum |
| Tamponade effect | Yes (liver tissue) | No |
| Bile leak risk | Low | Higher |
| Tract maturation | Faster | Slower (3-4 weeks minimum) |
| Indication | Standard approach | Transhepatic not feasible |
| Contraindication | Severe coagulopathy (relative) | Relative: interposed bowel |
Transhepatic approach (preferred): Needle traverses hepatic parenchyma before entering the gallbladder. Hepatic parenchyma provides a tamponade effect, reducing bile leak. Access through segment V (bare area of gallbladder adjacent to liver). Lower risk of bile peritonitis. Transperitoneal approach: Direct puncture of gallbladder through peritoneum. Used when transhepatic route is not feasible (intervening bowel, hepatic parenchymal disease). Higher risk of bile leak into peritoneum if catheter dislodges before tract matures. May need gastropexy-style anchoring.
Procedural Steps
Patient supine; ultrasound localization of gallbladder. Local anesthesia to skin, subcutaneous tissue, and peritoneum. Ultrasound-guided Seldinger or trocar technique: Seldinger: 18-21 gauge needle into gallbladder → aspirate bile → 0.035" wire → serial dilation → 8-10 Fr locking pigtail catheter. Trocar: combined needle-catheter system advanced directly into gallbladder under ultrasound guidance. Aspirate bile for culture and sensitivity. Optional cholecystogram: inject contrast to assess cystic duct patency and exclude perforation. Secure catheter to skin with suture and locking mechanism. Connect to gravity drainage bag.
<image>Ultrasound-guided transhepatic percutaneous cholecystostomy showing the drainage catheter traversing hepatic parenchyma with the pigtail coiled within the gallbladder lumen</image>
<image>Fluoroscopic cholecystogram through a percutaneous cholecystostomy tube showing opacification of the gallbladder, cystic duct, and common bile duct confirming cystic duct patency</image>
Post-Procedural Management
Immediate Care
Monitor drain output: initially bile-stained (green/yellow), may be purulent. Expected output: 100-300 mL/day. Continue IV antibiotics; tailor to culture results. Clinical improvement expected within 24-72 hours (fever, WBC, pain). Failure to improve: consider gangrenous cholecystitis, perforation, or other diagnosis.
Drain Management
Flush with 5-10 mL saline daily to maintain patency. Monitor for bile around catheter (suggests clogged or malpositioned drain). Tube check (cholecystogram) at 2-4 weeks to assess: Catheter position. Cystic duct patency. Stone burden. Tract maturation.
Capping Trial and Removal
If cystic duct is patent on cholecystogram → cap drain for 24-48 hours. If patient tolerates capping (no pain, fever) → consider drain removal. Tract should mature ≥3-4 weeks before removal (especially transperitoneal approach). Transhepatic tracts mature faster due to hepatic parenchymal support.
Controversy: Cholecystostomy as Destination Therapy vs. Bridge to Surgery
Bridge to Cholecystectomy
Traditional paradigm: cholecystostomy tube stabilizes patient → interval laparoscopic cholecystectomy at 4-8 weeks. Advantages: definitive stone removal, eliminates recurrence risk. Surgery may be more difficult due to inflammation and adhesions.
Destination Therapy
Many cholecystostomy patients never undergo cholecystectomy due to: Persistent surgical unfitness. Advanced age and comorbidities. Patient preference. CHOCOLATE trial (2012): early laparoscopic cholecystectomy superior to percutaneous drainage for high-risk patients — but study criticized for patient selection. Recent data suggest ~40-50% of cholecystostomy patients never proceed to cholecystectomy. Recurrence of cholecystitis after drain removal (without cholecystectomy): 20-40%.
Current Practice
Multidisciplinary discussion essential (IR, surgery, critical care). Drain removal without cholecystectomy is reasonable in patients with: Patent cystic duct. No stones or sludge. Prohibitive surgical risk. Resolution of acute illness. Patients with gallstones and reasonable surgical fitness should be strongly considered for interval cholecystectomy.
Complications
Common
Catheter dislodgement (most common complication — 5-10%). Pain at insertion site. Vasovagal reaction during procedure.
Uncommon / Serious
Bile leak/bile peritonitis (especially transperitoneal approach with premature drain removal). Hemorrhage (hepatic parenchyma, intercostal vessels, cystic artery). Bowel injury from inadvertent puncture (transperitoneal approach). Sepsis (from manipulation of infected gallbladder). Catheter occlusion from stones, sludge, or clot. Pneumothorax (rare, high transhepatic puncture).
Clinical Pearls
The transhepatic route is strongly preferred — it provides a tamponade effect and reduces bile leak risk compared with transperitoneal access. Always send aspirated bile for culture; acalculous cholecystitis in ICU patients is often caused by gram-negative organisms and anaerobes. If a patient fails to improve within 48-72 hours of cholecystostomy, consider gangrenous cholecystitis or gallbladder perforation — these may require emergent surgery regardless of risk status. Before removing a cholecystostomy tube, always perform a cholecystogram to confirm cystic duct patency and absence of retained stones. Wait at least 3-4 weeks for tract maturation before removing the drain — premature removal of a transperitoneal drain can cause bile peritonitis. Cholecystostomy is not a treatment for CBD stones — if choledocholithiasis is present, separate biliary intervention (ERCP or PTC) is needed. The decision between destination therapy and bridge-to-surgery must be individualized — many frail elderly patients do well with drain removal alone if the cystic duct is patent and stones are absent.
<image>Algorithm for management of acute cholecystitis in high-risk surgical patients showing decision pathways for percutaneous cholecystostomy placement, interval cholecystectomy, and drain removal criteria</image>
References
- Defined SIR Quality Improvement Guidelines for Percutaneous Cholecystostomy. J Vasc Interv Radiol. 2012;23(6):868-874.
- Defined JH, et al. CHOCOLATE Trial: Laparoscopic Cholecystectomy vs. Percutaneous Catheter Drainage for Acute Cholecystitis in High-Risk Patients. Ann Surg. 2012;256(6):909-914.
- Defined NA, et al. Percutaneous Cholecystostomy: Current Role in Clinical Practice. Cardiovasc Intervent Radiol. 2021;44(5):693-701.
- Defined WD, et al. Outcome of Percutaneous Cholecystostomy in Critically Ill Patients. AJR Am J Roentgenol. 2014;203(6):1326-1331.
- Horn T, et al. Percutaneous Cholecystostomy Is an Effective Treatment Option for Acute Calculous Cholecystitis. Am J Surg. 2015;210(5):906-911.
